Report date: Mar 26, 2024 Conflict count: 356923 Publisher: Bentham Science Title count: 75 Conflict count: 333 ========================================================== Created: 2015-11-26 06:36:10.0 ConfID: 5070606 CauseID: 1387545774 OtherID: 1354687917 JT: Current Pharmaceutical Biotechnology MD: Jawien, 13 ,13,2435,2012,The Role of An Experimental Model of Atherosclerosis: apoE-knockout Mice in Developing New Drugs against Atherogenesis DOI: 10.2174/138920112804583023(Journal) (5070606-N ) DOI: 10.2174/1389201011208062435(Journal) ========================================================== Created: 2015-11-26 06:36:10.0 ConfID: 5070607 CauseID: 1387545774 OtherID: 1354687917 JT: Current Pharmaceutical Biotechnology MD: Depukat, 13 ,13,2440,2012,Regeneration of Vessel Wall Functionality and Vascular Restoration Therapy with Biodegradable Stents - Current Status DOI: 10.2174/138920112804583014(Journal) (5070607-N ) DOI: 10.2174/1389201011208062440(Journal) ========================================================== Created: 2015-11-26 06:36:10.0 ConfID: 5070608 CauseID: 1387545774 OtherID: 1354687917 JT: Current Pharmaceutical Biotechnology MD: Jankowski, 13 ,13,2449,2012,How Drugs Influencing Central Blood Pressure Prevent Atherosclerosis Complications? DOI: 10.2174/138920112804583078(Journal) (5070608-N ) DOI: 10.2174/1389201011208062449(Journal) ========================================================== Created: 2015-11-26 06:36:10.0 ConfID: 5070610 CauseID: 1387545774 OtherID: 1354687917 JT: Current Pharmaceutical Biotechnology MD: W. Friedrich, 13 ,13,2467,2012,Genetics of Hypertrophic and Dilated Cardiomyopathy DOI: 10.2174/138920112804583041(Journal) (5070610-N ) DOI: 10.2174/1389201011208062467(Journal) ========================================================== Created: 2015-11-26 06:36:10.0 ConfID: 5070611 CauseID: 1387545774 OtherID: 1354687917 JT: Current Pharmaceutical Biotechnology MD: Bela Kertesz, 13 ,13,2477,2012,Fabry Disease Cardiomyopathy: from Genes to Clinical Manifestations DOI: 10.2174/138920112804583069(Journal) (5070611-N ) DOI: 10.2174/1389201011208062477(Journal) ========================================================== Created: 2015-11-26 06:36:10.0 ConfID: 5070612 CauseID: 1387545774 OtherID: 1354687917 JT: Current Pharmaceutical Biotechnology MD: Falcao-Pires, 13 ,13,2485,2012,Understanding the Molecular and Cellular Changes Behind Aortic Valve Stenosis DOI: 10.2174/138920112804583050(Journal) (5070612-N ) DOI: 10.2174/1389201011208062485(Journal) ========================================================== Created: 2015-11-26 06:36:10.0 ConfID: 5070613 CauseID: 1387545774 OtherID: 1354687917 JT: Current Pharmaceutical Biotechnology MD: Petkow Dimitrow, 13 ,13,2497,2012,Pharmacotherapy of Aortic Stenosis-Success or Failure? DOI: 10.2174/138920112804583096(Journal) (5070613-N ) DOI: 10.2174/1389201011208062497(Journal) ========================================================== Created: 2015-11-26 06:36:10.0 ConfID: 5070614 CauseID: 1387545774 OtherID: 1354687917 JT: Current Pharmaceutical Biotechnology MD: Gavina, 13 ,13,2503,2012,Left Ventricular Hypertrophy in Isolated Aortic Stenosis: Primetime for the Ventricle DOI: 10.2174/138920112804583032(Journal) (5070614-N ) DOI: 10.2174/1389201011208062503(Journal) ========================================================== Created: 2015-11-26 06:36:10.0 ConfID: 5070615 CauseID: 1387545774 OtherID: 1354687917 JT: Current Pharmaceutical Biotechnology MD: Papp, 13 ,13,2515,2012,How Cardiomyocytes Make the Heart Old DOI: 10.2174/138920112804583104(Journal) (5070615-N ) DOI: 10.2174/1389201011208062515(Journal) ========================================================== Created: 2015-11-26 06:36:10.0 ConfID: 5070616 CauseID: 1387545774 OtherID: 1354687917 JT: Current Pharmaceutical Biotechnology MD: Hamdani, 13 ,13,2522,2012,Alteration of the Beta-Adrenergic Signaling Pathway in Human Heart Failure DOI: 10.2174/138920112804582998(Journal) (5070616-N ) DOI: 10.2174/1389201011208062522(Journal) ========================================================== Created: 2015-11-26 06:36:10.0 ConfID: 5070617 CauseID: 1387545774 OtherID: 1354687917 JT: Current Pharmaceutical Biotechnology MD: Czuriga, 13 ,13,2532,2012,Cellular Mechanisms for Diastolic Dysfunction in the Human Heart DOI: 10.2174/138920112804583005(Journal) (5070617-N ) DOI: 10.2174/1389201011208062532(Journal) ========================================================== Created: 2015-11-26 06:36:10.0 ConfID: 5070618 CauseID: 1387545774 OtherID: 1354687917 JT: Current Pharmaceutical Biotechnology MD: Kasner, 13 ,13,2539,2012,Diastolic Heart Failure and LV Dyssynchrony DOI: 10.2174/138920112804582989(Journal) (5070618-N ) DOI: 10.2174/1389201011208062539(Journal)